Jpmorgan Chase & CO Sight Sciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 99,902 shares of SGHT stock, worth $710,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99,902
Previous 99,902 -0.0%
Holding current value
$710,303
Previous $343,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$3.27 - $4.25 $178,630 - $232,164
-54,627 Reduced 35.35%
99,902 $343,000
Q1 2025

May 12, 2025
BUY
$2.36 - $3.58 $113,700 - $172,477
48,178 Added 45.3%
154,529 $370,000
Q4 2024

Feb 12, 2025
BUY
$3.36 - $6.18 $123,281 - $226,750
36,691 Added 52.67%
106,351 $387,000
Q3 2024

Dec 26, 2024
BUY
$5.49 - $8.31 $294,582 - $445,897
53,658 Added 335.32%
69,660 $438,000
Q3 2024

Nov 08, 2024
BUY
$5.49 - $8.31 $294,582 - $445,897
53,658 Added 335.32%
69,660 $438,000
Q2 2024

Dec 26, 2024
SELL
$5.13 - $7.15 $275,265 - $383,654
-53,658 Reduced 77.03%
16,002 $106,000
Q2 2024

Aug 12, 2024
SELL
$5.13 - $7.15 $4.91 Million - $6.85 Million
-957,915 Reduced 98.36%
16,002 $106,000
Q1 2024

Dec 26, 2024
BUY
$4.02 - $5.89 $3.64 Million - $5.33 Million
904,257 Added 1298.1%
973,917 $5.14 Million
Q1 2024

May 10, 2024
SELL
$4.02 - $5.89 $577,738 - $846,487
-143,716 Reduced 12.86%
973,917 $5.14 Million
Q4 2023

Dec 26, 2024
BUY
$1.29 - $5.86 $1.35 Million - $6.14 Million
1,047,973 Added 1504.41%
1,117,633 $5.77 Million
Q4 2023

Feb 12, 2024
BUY
$1.29 - $5.86 $88,820 - $403,478
68,853 Added 6.57%
1,117,633 $5.77 Million
Q3 2023

Nov 14, 2023
SELL
$2.88 - $8.8 $199,298 - $608,968
-69,201 Reduced 6.19%
1,048,780 $3.53 Million
Q2 2023

Aug 11, 2023
BUY
$7.46 - $10.67 $4.24 Million - $6.06 Million
568,135 Added 103.33%
1,117,981 $9.26 Million
Q1 2023

May 18, 2023
BUY
$8.44 - $13.35 $140,863 - $222,811
16,690 Added 3.13%
549,846 $4.81 Million
Q1 2023

May 11, 2023
SELL
$8.44 - $13.35 $62,540 - $98,923
-7,410 Reduced 1.37%
533,156 $4.66 Million
Q4 2022

Feb 13, 2023
BUY
$5.58 - $13.94 $2.95 Million - $7.37 Million
528,955 Added 4555.64%
540,566 $6.6 Million
Q3 2022

Nov 14, 2022
SELL
$6.1 - $11.41 $7.09 Million - $13.3 Million
-1,161,668 Reduced 99.01%
11,611 $74,000
Q2 2022

Aug 11, 2022
BUY
$6.61 - $11.99 $209,113 - $379,315
31,636 Added 2.77%
1,173,279 $10.5 Million
Q1 2022

May 11, 2022
SELL
$11.56 - $17.9 $277,937 - $430,369
-24,043 Reduced 2.06%
1,141,643 $13.2 Million
Q4 2021

Feb 10, 2022
SELL
$17.36 - $27.36 $676,189 - $1.07 Million
-38,951 Reduced 3.23%
1,165,686 $20.5 Million
Q3 2021

Nov 12, 2021
BUY
$22.34 - $39.1 $26.9 Million - $47.1 Million
1,204,637 New
1,204,637 $27.3 Million

Others Institutions Holding SGHT

# of Institutions
83
Shares Held
20.6M
Call Options Held
0
Put Options Held
0
View Full List

About Sight Sciences, Inc.

SGHT Quotes by TradingView
  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $340M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email